Treatment of multiple sclerosis - PDFSEARCH.IO - Document Search Engine

Treatment of multiple sclerosis
Results: 202

#	Item
31	MSSocietyWA_32ppA4_TheBulletin_Autumn14_V8.indd Add to Reading List Source URL: d1qmnn0xkv8u83.cloudfront.net Language: English - Date: 2014-04-11 01:45:07 Medicine Treatment of multiple sclerosis National Multiple Sclerosis Society National Capital Chapter MS Walk Multiple sclerosis Health MS Australia
32	PDF Document Add to Reading List Source URL: www.msif.org Language: English - Date: 2014-10-14 05:07:05 Multiple Sclerosis International Federation Statistics .ms Treatment of multiple sclerosis Prevalence Epidemiology MS Australia Chronic cerebrospinal venous insufficiency Multiple sclerosis Health Medicine
33	Microsoft Word - Sanofi- 5.1 alemtuzumabPSD final.docx Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-04-22 23:39:46 Immunosuppressants Medicine Cytokines Autoimmune diseases Treatment of multiple sclerosis Glatiramer acetate Natalizumab Fingolimod Interferon beta-1a Immunology Immune system Multiple sclerosis
34	Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium IMI PROTECT WP5 IMI Report 2:b:iv NATALIZUMAB WAVE 2 CASE STUDY REPORT Review of methodologies for benefit and Add to Reading List Source URL: protectbenefitrisk.eu Language: English - Date: 2014-07-16 01:09:14 Multiple sclerosis Immune system Autoimmune diseases Natalizumab Treatment of multiple sclerosis Progressive multifocal leukoencephalopathy Fingolimod JC virus Glatiramer acetate Immunology Medicine Immunosuppressants
35	Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium IMI WP5 Report 1:b:iv Benefit-Risk Wave 1 case study report: NATALIZUMAB Risk benefit case study with a focus on testing methodology. Add to Reading List Source URL: protectbenefitrisk.eu Language: English - Date: 2014-07-16 01:09:12 Multiple sclerosis Health Autoimmune diseases Natalizumab Treatment of multiple sclerosis Progressive multifocal leukoencephalopathy Fingolimod JC virus Glatiramer acetate Immunology Medicine Immunosuppressants
36	Post-market Review of Authority Required PBS Listings: Public Consultation Submission from Biogen Idec (Australia) Pty Ltd regarding disease-modifying therapies for Multiple Sclerosis (first tranche of reviews) Dear PBAC Add to Reading List Source URL: pbs.gov.au Language: English - Date: 2015-03-02 18:33:43 Immunosuppressants Cytokines Pharmacology Autoimmune diseases Monoclonal antibodies Biogen Idec Natalizumab Interferon beta-1a Treatment of multiple sclerosis Immunology Immune system Multiple sclerosis
37	Physical Actitivty in the Prevention of Treatment and Desease Add to Reading List Source URL: fyss.se Language: English - Date: 2011-06-20 11:53:02 Anatomy Exercise Multiple sclerosis Neurological disorders Autoimmune diseases Fatigue Physical exercise Physical Activity Guidelines for Americans Strength training Health Medicine Exercise physiology
38	Treatments for MS: TECFIDERA® (dimethyl fumarate) There are currently nine disease-modifying therapies approved for people with MS in Australia. These therapies, called immunotherapies, work to reduce disease activity i Add to Reading List Source URL: www.msaustralia.org.au Language: English - Date: 2014-01-21 00:35:16 Immune system MS Australia Immunotherapy Dimethyl fumarate Therapies under investigation for multiple sclerosis Treatment of multiple sclerosis Multiple sclerosis Medicine Immunology
39	Living Well with MS Fact Sheet What is Multiple Sclerosis? Multiple sclerosis (MS) is a disease of the central nervous system (CNS) affecting the brain, spinal cord and optic nerves. The CNS acts as the body’s messeng Add to Reading List Source URL: d1qmnn0xkv8u83.cloudfront.net Language: English - Date: 2013-10-22 04:45:48 Health Anatomy Neurological disorders Myelin Treatment of multiple sclerosis Pathophysiology of multiple sclerosis Multiple sclerosis Autoimmune diseases Immune system
40	February 5, 2014 New treatment gives hope to MS patients The Multiple Sclerosis Society of WA (MSWA) CEO Marcus Stafford says the breakthrough in the treatment of progressive multiple sclerosis (MS) by Australian resear Add to Reading List Source URL: d1qmnn0xkv8u83.cloudfront.net Language: English - Date: 2014-02-24 22:00:06 Health Immunotherapy Corinne Goldsmith Dickinson Center for Multiple Sclerosis Medwell Capital Multiple sclerosis Medicine Immune system

UPDATE